Catalyst Wire Dossier Catalyst Wire Dossier

AKOVAZ

ephedrine sulfate · Exela Pharma Sciences, LLC
Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for AKOVAZ, covering 2016-04-29 to 2021-08-02. Get the full timeline:

Most recent: FDA Approved: AKOVAZ — Supplemental Application (Exela Pharma Sciences, LLC)

See pricing